Government-funded treatments that could tackle the root causes of knee osteoarthritis are now about to reach clinical trials.
At the end of the five-year grant period, researchers plan to submit a new drug or biological product application with the ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, randomized controlled trial highlighting the clinical ...
The California Institute for Regenerative Medicine awarded Scripps Health $12.7 million to study using stem cells to repair ...
The approach being studied at Scripps is for larger knee injuries, where the damage to the cartilage and underlying bone are ...
Scripps Health has received $12.7 million in grant funding from the California Institute for Regenerative Medicine (CIRM) to ...
It was, in many ways, an accidental comeback for Shoriful in the first ODI of the three-match series against New Zealand in ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, randomized controlled trial highlighting the clinical superiorit ...
Kineon MOVE+ Pro uses a combination of red and near-infrared light, claiming it provides pain relief, potentially reduces ...
Natural extracts from turmeric and ginger enhance implant bonding, fight infection, and reduce cancer cells, offering a promising improvement for medical implants.
New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
Not being able to stay on the floor bothered the two-time All-Star. He's trying to work smarter, not harder, to change that.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results